eXoZymes, Inc. is a synthetic biochemical company in the United States. The company is headquartered in Monrovia, California.
| Revenue (TTM) | -700 |
| Gross Profit (TTM) | -700 |
| EBITDA | $-9.43M |
| Operating Margin | 0.00% |
| Return on Equity | -132.60% |
| Return on Assets | -63.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.40 |
| Price-to-Book | 21.81 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $8.48M |
| Float | $6.33M |
| % Insiders | 70.95% |
| % Institutions | 0.74% |
Volatility is currently expanding